MBL Wealth
ALNY icon

MBL Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

MBL Wealth’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$396K Buy
+1,603
New +$408K 0.02% 368

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

MBL Wealth's ALNY Position: Q3 2026 in Review

MBL Wealth opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 1,603 shares worth $396K. The stake represents 0.02% of the portfolio and ranks #368 among its holdings.

540 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • MBL Wealth held 1,603 shares of Alnylam Pharmaceuticals worth $396K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new MBL Wealth position in Q3 2026.
  • Alnylam Pharmaceuticals made up 0.02% of MBL Wealth's portfolio in Q3 2026, its #368 holding.
  • 540 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.